TNBC, the most aggressive type of breast cancer, is characterized by the absence of estrogen receptors (ER) and progesterone receptors (PR) and the amplification of human epidermal growth factor receptor 2 (HER2) [2,3,4]. This evidence concerns the gene ESR1 and breast carcinoma.